Absolute quantification of graft-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation – results from a prospective observational trial (Oellerich et al. AACC 2018)

Download PDF

By | August 28th, 2018|Medical publications, Transplant|0 Comments

Schütz E et al. Graft-derived cell-free DNA – a promising rejection marker in cardiac transplantation – Results from a prospective observational trial. 69th AACC Annual Scientific Meeting Abstract eBook (2017):A-121

Download PDF

By | August 28th, 2018|Medical publications, Transplant|0 Comments

Schütz E et al. Graft-derived cell-free DNA a promising Rejection Marker in Liver transplantation Results from a prospective Multicenter Trial. Clin Chem (2016): suppl. A121

Download PDF

By | August 28th, 2018|Medical publications, Transplant|0 Comments

Beck J et al. A new universal multiplex digital PCR method with improved precision for the quantification of donor derived graft DNA traces Clin Chem (2015): suppl

Download PDF

By | August 28th, 2018|Medical publications, Transplant|0 Comments

Beck J et al. Early Detection of Rejection after Heart Transplantation by a universal digital PCR method Clin Chem (2015): suppl

Download PDF

By | August 28th, 2018|Medical publications, Transplant|0 Comments

Beck J et al. Use Of Plasma GcfDNAQuantification To Guide Personalized Immunosuppression. Transplant International 27 (2014): 50

Download PDF

By | August 28th, 2018|Medical publications, Transplant|0 Comments

Beck J et al. Absolute Quantification of Graft derived cell-free DNA (GcfDNA) early after Liver Transplantation (LTx) using droplet Digital PCR. Clin Chem 2015: suppl

Download PDF

By | August 28th, 2018|Medical publications, Transplant|0 Comments

Madappa N. Kundranda, MD, PhD. Director, Gastrointestinal Oncology Program, Adjunct Assistant Professor, University of Texas MD Anderson Cancer Center,Banner MD Anderson, Arizona.

Experts on Chronix Biomedical CNI Monitor test. Testing for drug efficacy. #TheTurningPointInCancerFight

By | July 10th, 2017|Video|0 Comments

Early detection of cancer – why is it important?

The number of people diagnosed with tumors, especially malignant ones, is constantly increasing. There is also a rise in mortality rate due to delayed diagnosis and inappropriate treatment. Therefore, proper cancer diagnosis is very important. Early detection of a tumor makes it more probable that the patient will, finally, beat the cancer and recover. However, [...]

By | July 6th, 2017|Chronix news|0 Comments

Chronix ASCO 2017: Dr Glen Weiss

Experts on Chronix Biomedical CNI Monitor test. Testing for drug efficacy. #TheTurningPointInCancerFight

By | July 3rd, 2017|Video|0 Comments